Food and Drug Administration (FDA)
NEWS
Tukysa came out of Project Orbis, a multinational partnership between the FDA, the Australian Therapeutic Goods Administration, Health Canada, Health Sciences Authority and Swissmedic.
Here’s a look at what’s on the U.S. Food and Drug Administration’s schedule for the next two weeks.
The agency issued a statement saying that it will continue its activities, such as reviewing new drug applications and clinical trial, both COVID-19 and non-COVID-19, applications, “as we do everything possible to maintain continuity of operations in a very dynamic situation.”
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 17, 2020.
Jelmyto is the first and only non-surgical treatment for patients with this indication. Here’s everything you need to know about it.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 15, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
The U.S. Food and Drug Administration granted emergency use authorization to Rutgers’ RUCDR Infinite Biologics for its test that uses saliva.
JOBS
IN THE PRESS